WANBURY
Back to All Ratios
|
WANBURY Last 5 Year EV/CE History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EV/CE(x) | 4.22 | 5.84 | 0.92 | 1.26 | 0.70 |
What is the latest EV/CE ratio of WANBURY ?
Year | EV/CE |
---|---|
Mar2024 | 4.22 |
Mar2023 | 5.84 |
Mar2022 | 0.92 |
Mar2021 | 1.26 |
Mar2020 | 0.70 |
How is EV/CE of WANBURY Trending?
Years | EV/CE | % Change | |
---|---|---|---|
Mar2024 | 4.22 | -27.74 | |
Mar2023 | 5.84 | 534.78 | |
Mar2022 | 0.92 | -26.98 | |
Mar2021 | 1.26 | 80.00 | |
Mar2020 | 0.7 | - |
Other Financial Ratios of WANBURY
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/CE ratio of peers of WANBURY
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WANBURY | ₹826.4 Cr | -13.1% | -17.9% | 103.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹438,143.0 Cr | -1.2% | 0.9% | 41.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹154,578.0 Cr | -3.7% | -1.8% | 46.1% | Stock Analytics | |
CIPLA | ₹120,185.0 Cr | -1.5% | 2.2% | 16.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹114,450.0 Cr | 1.4% | 10.6% | 17.2% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹101,569.0 Cr | 3.5% | 3.6% | 37.4% | Stock Analytics |
WANBURY Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WANBURY | -13.1% |
-17.9% |
103.4% |
SENSEX | -2.9% |
-4.8% |
8% |
You may also like the below Video Courses